Concord Biotech Limited (CONCORDBIO)
₹2,171.7
INR-9.40(-0.43%)
As of December 6, 2024 10:00:00 AMConcord Biotech Limited Share Price Information
24 hour Low and High
The lowest and highest prices reached in the last 24 hours of trading
Low: ₹2143.1
High: ₹2207
All time High
The highest price the stock has ever reached since being listed
₹2601.10
Price Change 1h
Price change in the last hour of trading
+₹-6.55 +-0.30%
Price Change 1d
Price change over the last trading day
+₹-6.55 +-0.30%
Price Change 1w
Price change over the last week of trading
+₹273.95 +14.44%
Concord Biotech Limited Market Information
Exchange
The Exchange where the trading of the stock takes place
NSE
Market Cap
The current market capitalisation of the stock
19166.90 Cr
About Concord Biotech Limited Share
Concord Biotech Limited, a biopharma company, engages in the research and development, manufacturing, marketing, and sale of pharmaceutical products in India and internationally. The company provides fermentation based active pharmaceutical ingredients in immunosuppressants, anti-bacterial, oncology, antifungal, and other therapeutic areas. It also offers tacrolimus, mycophenolate mofetil, mycophenolate sodium, cyclosporine, sirolimus, and pimecrolimus for immunosuppressants therapeutic segment; temsirolimus, everolimus, romidepsin, mitomycin, midostaurin, dactinomycin, staurosporin, mitoguazone, and everolimus premix for oncology therapeutic segment; mupirocin, mupirocin calcium, polymyxin B sulfate, fidaxomicin, vancomycin hydrochloride, and teicoplanin for anti-bacterial applications; anidulafungin, caspofungi, micafungin sodium, amphotericin B, and nystatin for anti-fungal therapeutic segment; and lovastatin, pravastatin sodium, and enzymes for other applications. In addition, it provides contract research and manufacturing services in the areas of fermentation and semi-synthesis products. Concord Biotech Limited was incorporated in 1984 and is based in Ahmedabad, India.
Sector
Healthcare
Biotechnology
Employees
about
1377
CEO
Mr. Ankur Vaid
Revenue (2023)
%
Country of Origin
India
Key Highlights
- Is this Jhunjhunwala-backed pharma stock still a buy after 30% correction?
- UBS sells shares worth Rs 480 crore in Concord Biotech, IIFL Securities, 2 more stocks via block deals
- Is Concord Biotech Limited's (NSE:CONCORDBIO) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
- Concord Biotech shares hit all time high; Antique Broking reiterates 'Buy'
- Concord Biotech shares rally over 12% to hit new record highs; check details
Concord Biotech Limited Resource
FAQs
The current price of Concord Biotech Limited is INR 2171.70 — it has changed by -0.30% in the past 24 hours. Watch Concord Biotech Limited's stock price performance more closely on the chart.
Concord Biotech Limited has a market capitalization of 191669026816 as of today.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Concord Biotech Limited's EBITDA is INR undefined
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange Concord Biotech Limited stocks are traded under the ticker [object Object]
As of December 08, 2024, the company has 1377 employees.